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Background
The human immunodeficiency virus type 1 (HIV-1)
infection occurs by binding to CD4+ receptor and che-
mokine receptor 5 (CCR5) or the CXC chemokine
receptor (CXCR4). A mutation in the CCR5 gene, 32
base pair deletion consequences a truncated protein that
is not expressed on the cell surface. The deletion con-
fers resistance to HIV-1 infection and slows the progres-
sion of AIDS in HIV infected individuals. The
worldwide distribution of CCR5delta 32 polymorphism
was congregated by retrieving the data from literature
and genotyping new population samples. A comprehen-
sive resource of frequency data for CCR5delta 32 poly-
morphism in different population samples was created.
Methods
The data for different populations was obtained from lit-
erature. In order to investigate the genetic variation in
CCR5 gene in new population, we analyzed 257 healthy
control individuals. We examined the CCR5 32 base
pair deletion (CCR5-Δ32) by conventional polymerase
chain reaction (PCR).
Results
The genotype frequency distribution of CCR5 in new
population was found to be (CCR5 / CCR5: 98%, CCR5
/ CCR5-Δ32: 2% and CCR5-Δ32 / CCR5-Δ32: 0%) in
healthy control.
Conclusion
The allele frequency of CCR5-Δ32 observed for new
population is 1% which is compared with the other
populations. The polymorphism CCR5-Δ32 is primarily
found in European population. Compared to our data,
frequency of delta 32 deletion is observed at high fre-
quency in European populations. Our data of delta 32
deletion is significantly different from Caucasians
(p<0.00000001), Africans (p<0.01458) and Europeans
(p< 0.00000001).
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